Lisata Therapeutics, Inc. (LSTA) stock
LSTANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.21−0.07 (-5.47%)
Close on Nov 13, 2026Market cap $10.90MP/E –Yield –
Lisata Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Lisata Therapeutics's total assets was $648.41M at Sep 30, 2026. For fiscal 2025 it was $17.74M, down 49.3% from the year before. Over ten years it grew -11.0% a year on average. The highest annual figure on record is $155.33M in fiscal 2011.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.74M | -49.3% |
| FY2024 | Dec 31, 2024 | $35.00M | -36.0% |
| FY2023 | Dec 31, 2023 | $54.69M | -25.1% |
| FY2022 | Dec 31, 2022 | $73.03M | -24.7% |
| FY2021 | Dec 31, 2021 | $97.01M | +169.5% |
| FY2020 | Dec 31, 2020 | $36.00M | +32.6% |
| FY2019 | Dec 31, 2019 | $27.15M | -39.1% |
| FY2018 | Dec 31, 2018 | $44.58M | -29.7% |
| FY2017 | Dec 31, 2017 | $63.38M | +18.4% |
| FY2016 | Dec 31, 2016 | $53.51M | -6.5% |
| FY2015 | Dec 31, 2015 | $57.21M | -54.7% |
| FY2014 | Dec 31, 2014 | $126.28M | +40.6% |
| FY2013 | Dec 31, 2013 | $89.82M | +65.1% |
| FY2012 | Dec 31, 2012 | $54.41M | -65.0% |
| FY2011 | Dec 31, 2011 | $155.33M | +8.6% |
| FY2010 | Dec 31, 2010 | $143.02M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $648.41M | +2880.0% |
| Q2 FY2026 | Jun 30, 2026 | $11.03M | -56.2% |
| Q1 FY2026 | Mar 31, 2026 | $14.06M | -51.5% |
| Q4 FY2025 | Dec 31, 2025 | $17.74M | -49.3% |
| Q3 FY2025 | Sep 30, 2025 | $21.76M | -43.0% |
| Q2 FY2025 | Jun 30, 2025 | $25.16M | -40.9% |
| Q1 FY2025 | Mar 31, 2025 | $28.98M | -39.9% |
| Q4 FY2024 | Dec 31, 2024 | $35.00M | -36.0% |
| Q3 FY2024 | Sep 30, 2024 | $38.20M | -34.2% |
| Q2 FY2024 | Jun 30, 2024 | $42.57M | -31.7% |
| Q1 FY2024 | Mar 31, 2024 | $48.24M | -27.3% |
| Q4 FY2023 | Dec 31, 2023 | $54.69M | -25.1% |
| Q3 FY2023 | Sep 30, 2023 | $58.09M | -26.0% |
| Q2 FY2023 | Jun 30, 2023 | $62.37M | -27.4% |
| Q1 FY2023 | Mar 31, 2023 | $66.33M | -27.5% |
| Q4 FY2022 | Dec 31, 2022 | $73.03M | -24.7% |
| Q3 FY2022 | Sep 30, 2022 | $78.53M | -23.4% |
| Q2 FY2022 | Jun 30, 2022 | $85.88M | -20.9% |
| Q1 FY2022 | Mar 31, 2022 | $91.46M | -20.2% |
| Q4 FY2021 | Dec 31, 2021 | $97.01M | +169.5% |
| Q3 FY2021 | Sep 30, 2021 | $102.54M | +144.0% |
| Q2 FY2021 | Jun 30, 2021 | $108.61M | +189.8% |
| Q1 FY2021 | Mar 31, 2021 | $114.61M | +417.6% |
| Q4 FY2020 | Dec 31, 2020 | $36.00M | +32.6% |
| Q3 FY2020 | Sep 30, 2020 | $42.02M | +32.7% |
| Q2 FY2020 | Jun 30, 2020 | $37.48M | +3.1% |
| Q1 FY2020 | Mar 31, 2020 | $22.14M | -46.4% |
| Q4 FY2019 | Dec 31, 2019 | $27.15M | -39.1% |
| Q3 FY2019 | Sep 30, 2019 | $31.67M | -33.8% |
| Q2 FY2019 | Jun 30, 2019 | $36.35M | -30.2% |
| Q1 FY2019 | Mar 31, 2019 | $41.29M | -27.2% |
| Q4 FY2018 | Dec 31, 2018 | $44.58M | -29.7% |
| Q3 FY2018 | Sep 30, 2018 | $47.85M | -29.2% |
| Q2 FY2018 | Jun 30, 2018 | $52.09M | -27.9% |
| Q1 FY2018 | Mar 31, 2018 | $56.72M | +16.9% |
| Q4 FY2017 | Dec 31, 2017 | $63.38M | +18.4% |
| Q3 FY2017 | Sep 30, 2017 | $67.56M | – |
| Q2 FY2017 | Jun 30, 2017 | $72.25M | – |
| Q1 FY2017 | Mar 31, 2017 | $48.53M | – |
| Q4 FY2016 | Dec 31, 2016 | $53.51M | – |
See a number that looks wrong?